New drug may let kids with hemophilia play sports safer

NCT ID NCT05022459

Recruiting now Disease control Sponsor: Wayne State University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study looks at whether Emicizumab, a newer drug, prevents bleeding during sports better than standard Factor VIII in children with moderate to severe hemophilia A. About 72 kids aged 6 to 19 who already play sports and take one of these drugs will be followed. The goal is to see which drug leads to fewer bleeds during physical activity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Emicizumab and Factor VIII
What this could lead to: If Emicizumab works better, it could allow kids with hemophilia A to play sports with fewer bleeds and less frequent injections.
What could go wrong: This is a small, early-stage study (72 participants) comparing two existing drugs, so results may not apply to all patients. Bleeding risk remains.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hemophilia A

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMOPHILIA A

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Arkansas Children's Hospital
RECRUITING

Little Rock, Arkansas, 72202, United States

Contact Email: •••••@•••••
Boston Children's Hospital
RECRUITING

Boston, Massachusetts, 02215, United States

Contact Email: •••••@•••••
Children's Hospital of Michigan
RECRUITING

Detroit, Michigan, 48201, United States

Contact Email: •••••@•••••
Cincinnati Children's Hospital Medical Center
RECRUITING

Cincinnati, Ohio, 45229, United States

Contact Email: •••••@•••••
Indiana Hemophilia & Thrombosis Center
RECRUITING

Indianapolis, Indiana, 46260, United States

Contact Email: •••••@•••••
Johns Hopkins All Children's Hospital
RECRUITING

St. Petersburg, Florida, 33701, United States

Contact Email: •••••@•••••
Oklahoma Center for Bleeding and Clotting Disorders
RECRUITING

Oklahoma City, Oklahoma, 73104, United States

Contact Email: •••••@•••••
Rady Children's Hospital
RECRUITING

San Diego, California, 92123, United States

Contact Email: •••••@•••••
Rush University Children's Hospital
RECRUITING

Chicago, Illinois, 60612, United States

Contact Email: •••••@•••••
Stanford University
RECRUITING

Palo Alto, California, 94304, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.